Trial NCT03572634

View at ClinicalTrials.gov 
Org. Study IDs: TP-0903-102

Last trial update was posted on 2023-11-09

MeSH Interventions

Ibrutinib

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

CLL Chronic Lymphocytic Leukemia SLL Small Lymphocytic Lymphoma

Stopping Reasons

Given the extensive time projected to conclude the study hypothesis, it is no longer feasible to include this study of TP-0903.

Limitations And Caveats

The study was stopped early (21 January 2020) due to low enrollment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID